Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Auranofin (Primary) ; Dolutegravir (Primary) ; Maraviroc (Primary) ; Nicotinamide (Primary)
- Indications HIV-1 infections
- Focus Proof of concept; Therapeutic Use
- 06 Nov 2017 Planned End Date changed from 1 Jul 2017 to 1 Mar 2019.
- 06 Nov 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Mar 2018.
- 27 Oct 2017 Results of an interim analysis assessing safety and efficacy of Auranofin in antiretrovirally supressed HIV-1-infected indiviudals, presented at the 16th European AIDS Conference